Stem Cell Pharma Inc.

Stem Cell Pharma Inc. (SCPI) is a privately held bio-pharmaceutical company founded in May of 2005, in Las Vegas, Nevada.

SCPI owns the world wide rights to an Invention "An Amniotic Membrane Stem Cell Telomerase Enhanced Implant, Manufacturing And Clinical Uses" by Alfred T. Sapse MD (r) its President and Founder. This invention is a novel approach of harvesting embryonic type stem cells from the amniotic membrane, a translucid sheet covering placenta. These cells can potentially repair and if needed rebuild practically all organs, tissues and cells, through a process of differentiation, once introduced in the human body.

The implant had been used with modest to substantial results in neuro degenerative diseases such a Multiple Sclerosis (MS), ALS (Lou Gehrig's Disease), Parkinson's, in eye diseases (Retinitis Pigmentosa - RP, Usher's Syndrome - RP plus deafness), Muscular Dystrophy (MDA) including Duchenne's, children diseases such as Cerebral Palsy (CP) and Epilepsy, autoimmune (Lupus Erythematosus (LE)), and especially in the treatment of symptoms of aging. There were no reports of infections or immune rejections. Clinical studies commenced in the US are now being carried out abroad, due to objections by the FDA.